Stock PORTAGE BIOTECH INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Portage Biotech Inc OTC Bulletin Board

Equities

CA09852M1014

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Portage Biotech Inc
03/06 Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May MT
03/06 Investors Await Key Manufacturing Data as US Futures Nudge Higher in Monday's Premarket Session MT

Chart calendar Portage Biotech Inc

669f326ad29b54d9.z9fx_xDsDwuF196061grZyG0Q4ktYSr5A1yPiIDvPvQ.q77Fkle6Ql_iopf2qRdxKkXOL_xHKH2fUmjm_bC8Vpiglbi1J99KOM6jlw~212af68c567ab32a82517a6f8b70e81e

Upcoming events on Portage Biotech Inc

29/07/2024 Q4 2024 Earnings Release (Projected)
26/08/2024 Q1 2025 Earnings Release (Projected)
26/11/2024 Q2 2025 Earnings Release (Projected)
26/02/2025 Q3 2025 Earnings Release (Projected)

Past events on Portage Biotech Inc

29/02/2024 03:40 am Q3 2024 Earnings Release
29/11/2023 02:31 am Q2 2024 Earnings Release
28/09/2023 07:50 pm Cantor Global Healthcare Conference
12/09/2023 H.C. Wainwright Global Investment Conference
30/08/2023 05:30 pm Q1 2024 Earnings Release
01/08/2023 01:35 am Q4 2023 Earnings Release
08/06/2023 07:45 pm BIO International Convention - Panel
14/03/2023 11:30 pm Oppenheimer Healthcare Conference
09/03/2023 09:00 pm Investor Meeting - Key Opinion Leader
01/03/2023 06:30 pm Q3 2023 Earnings Release
22/02/2023 07:30 pm Citi Virtual Oncology Leadership Summit
30/11/2022 03:13 am Interim 2023 Earnings Release
10/11/2022 09:00 pm Annual General Meeting
10/11/2022 07:30 pm Society for Immunotherapy of Cancer Meeting - Abstract No. - 745
29/08/2022 05:30 pm Q1 2023 Earnings Release
01/08/2022 05:30 pm FY 2022 Earnings Release
07/07/2022 06:00 pm Acquisition of Tarus Therapeutics by Portage Biotech, Inc Call
06/06/2022 American Society of Clinical Oncology Meeting - Abstract Number: 2520
06/06/2022 American Society of Clinical Oncology Meeting - Abstract Number: 11515
06/06/2022 American Society of Clinical Oncology Meeting - Abstract Number: 382017

Annual results

Fiscal PeriodMarch 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-15,6
-15,3
-1.84%		-16,6
-18,0
7.92%
-19,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-14,8
-15,1
2.19%		-123
-18,0
-580.68%
-62,4

Net income
Million USD		Released
Forecast
Spread 		-16,9
-13,7
-22.75%		-105
-16,0
-553.82%
-51,8

EPS
USD		Released
Forecast
Spread 		-1,29
-1,05
-22.86%		-6,49
-0,94
-590.43%
-2,72

Announcement Date01/08/2231/07/23-

Quarterly results

Fiscal PeriodMarch 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-4,17
-3,60
-15.81%		-4,50
-4,24
-6%		-4,09
-4,38
6.67%		-3,65
-4,20
13.04%		-4,76
-3,88
-22.75%		-4,08
-5,00
18.48%		-5,00
-4,18
-19.62%		-5,93
-4,63
-27.99%		-4,03
-5,84
31.06%
-4,40

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,09
-4,00
-2.23%		-4,05
-4,26
5.08%		-4,18
-4,35
3.87%		-3,64
-4,53
19.77%		-5,30
-3,88
-36.76%		-109
-5,00
-2088.1%		-6,07
-4,18
-45.33%		-6,07
-4,63
-31.06%		-48,9
-5,82
-740.07%
-4,35

Net income
Million USD		Released
Forecast
Spread 		-3,51
-3,78
7.04%		-7,32
-3,78
-93.83%		-1,73
-4,05
57.26%		-0,95
-4,53
79.07%		-7,49
-3,88
-93.06%		-94,4
-5,00
-1788.96%		-5,92
-4,18
-41.69%		-5,16
-4,63
-11.33%		-39,4
-5,82
-576.74%
-4,35

EPS
USD		Released
Forecast
Spread 		-0,26
-0,27
4.88%		-0,55
-0,28
-98.79%		-0,13
-0,30
56.18%		-0,06
-0,29
79.31%		-0,44
-0,23
-95.56%		-6,00
-0,27
-2122.22%		-0,33
-0,24
-37.5%		-0,29
-0,27
-7.41%		-1,88
-0,27
-596.3%
-0,22

Announcement Date24/02/2201/08/2229/08/2229/11/2201/03/2331/07/2329/08/2328/11/2328/02/24-

Upcoming sector events for Portage Biotech Inc

15/07/2024 11:15 am ADDLIFE AB: Q2 2024 Earnings Release
22/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
24/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
24/07/2024 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
25/07/2024 LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 10:30 am BACHEM HOLDING AG: Q2 2024 Earnings Release
26/07/2024 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 10:30 am BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for Portage Biotech Inc

30/05/2024 01:31 am IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 04:30 pm CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 10:30 am EVOTEC SE: Q1 2024 Earnings Release
22/05/2024 02:44 am ALVOTECH: Q1 2024 Earnings Release
21/05/2024 04:30 pm EXSCIENTIA PLC: Q1 2024 Earnings Release
17/05/2024 11:30 am BIOARCTIC AB: Q1 2024 Earnings Release
16/05/2024 01:35 am CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
15/05/2024 01:35 am KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. PRTG Stock
  4. Stock
  5. Calendar Portage Biotech Inc